Roberts, Glore & Co’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $606K | Buy |
6,997
+834
| +14% | +$79.9K | 0.17% | 119 |
|
|
2025
Q4 | $592K | Sell |
6,163
-935
| -13% | -$90.8K | 0.16% | 122 |
|
|
2025
Q3 | $676K | Hold |
7,098
| – | – | 0.18% | 107 |
|
|
2025
Q2 | $619K | Sell |
7,098
-130
| -2% | -$11K | 0.18% | 114 |
|
|
2025
Q1 | $650K | Sell |
7,228
-189
| -3% | -$16.9K | 0.2% | 108 |
|
|
2024
Q4 | $592K | Sell |
7,417
-145
| -2% | -$12.6K | 0.18% | 111 |
|
|
2024
Q3 | $681K | Sell |
7,562
-175
| -2% | -$14.7K | 0.2% | 107 |
|
|
2024
Q2 | $609K | Sell |
7,737
-131
| -2% | -$10.7K | 0.18% | 108 |
|
|
2024
Q1 | $686K | Sell |
7,868
-220
| -3% | -$18.8K | 0.21% | 103 |
|
|
2023
Q4 | $666K | Sell |
8,088
-642
| -7% | -$48.9K | 0.21% | 100 |
|
|
2023
Q3 | $684K | Sell |
8,730
-450
| -5% | -$37.7K | 0.23% | 93 |
|
|
2023
Q2 | $809K | Sell |
9,180
-125
| -1% | -$10.8K | 0.26% | 91 |
|
|
2023
Q1 | $750K | Sell |
9,305
-130
| -1% | -$10.6K | 0.25% | 87 |
|
|
2022
Q4 | $733K | Sell |
9,435
-39
| -0.4% | -$3.16K | 0.25% | 90 |
|
|
2022
Q3 | $765K | Sell |
9,474
-205
| -2% | -$18.4K | 0.27% | 85 |
|
|
2022
Q2 | $869K | Sell |
9,679
-50
| -0.5% | -$5.07K | 0.29% | 84 |
|
|
2022
Q1 | $1.08M | Sell |
9,729
-10
| -0.1% | -$1.06K | 0.31% | 75 |
|
|
2021
Q4 | $1.01M | Buy |
9,739
+5
| +0.1% | +$579 | 0.26% | 84 |
|
|
2021
Q3 | $1.22M | Buy |
9,734
+400
| +4% | +$51.8K | 0.37% | 66 |
|
|
2021
Q2 | $1.16M | Sell |
9,334
-6
| -0.1% | -$753 | 0.35% | 70 |
|
|
2021
Q1 | $1.1M | Sell |
9,340
-175
| -2% | -$20.5K | 0.35% | 71 |
|
|
2020
Q4 | $1.11M | Hold |
9,515
| – | – | 0.36% | 68 |
|
|
2020
Q3 | $988K | Buy |
9,515
+147
| +2% | +$14.8K | 0.35% | 67 |
|
|
2020
Q2 | $859K | Sell |
9,368
-288
| -3% | -$27.6K | 0.34% | 71 |
|
|
2020
Q1 | $870K | Buy |
9,656
+35
| +0.4% | +$3.72K | 0.37% | 67 |
|
|
2019
Q4 | $1.09M | Buy |
9,621
+2,781
| +41% | +$305K | 0.42% | 64 |
|
|
2019
Q3 | $743K | Buy |
6,840
+597
| +10% | +$62.3K | 0.45% | 64 |
|
|
2019
Q2 | $608K | Hold |
6,243
| – | – | 0.37% | 73 |
|
|
2019
Q1 | $569K | Hold |
6,243
| – | – | 0.36% | 75 |
|
|
2018
Q4 | $568K | Sell |
6,243
-500
| -7% | -$46.7K | 0.4% | 72 |
|
|
2018
Q3 | $663K | Hold |
6,743
| – | – | 0.38% | 77 |
|
|
2018
Q2 | $577K | Sell |
6,743
-410
| -6% | -$34.2K | 0.35% | 84 |
|
|
2018
Q1 | $574K | Hold |
7,153
| – | – | 0.35% | 80 |
|
|
2017
Q4 | $578K | Sell |
7,153
-220
| -3% | -$17.6K | 0.35% | 80 |
|
|
2017
Q3 | $573K | Sell |
7,373
-255
| -3% | -$21.2K | 0.37% | 79 |
|
|
2017
Q2 | $677K | Sell |
7,628
-155
| -2% | -$13.1K | 0.45% | 66 |
|
|
2017
Q1 | $627K | Sell |
7,783
-995
| -11% | -$77.7K | 0.43% | 70 |
|
|
2016
Q4 | $625K | Hold |
8,778
| – | – | 0.44% | 72 |
|
|
2016
Q3 | $758K | Sell |
8,778
-565
| -6% | -$49.2K | 0.54% | 56 |
|
|
2016
Q2 | $811K | Sell |
9,343
-387
| -4% | -$31.3K | 0.62% | 51 |
|
|
2016
Q1 | $730K | Sell |
9,730
-3,431
| -26% | -$258K | 0.55% | 53 |
|
|
2015
Q4 | $1.01M | Sell |
13,161
-950
| -7% | -$71.5K | 0.77% | 43 |
|
|
2015
Q3 | $945K | Sell |
14,111
-1,290
| -8% | -$95K | 0.74% | 43 |
|
|
2015
Q2 | $1.14M | Sell |
15,401
-12,805
| -45% | -$978K | 0.8% | 40 |
|
|
2015
Q1 | $2.2M | Sell |
28,206
-3,118
| -10% | -$236K | 1.52% | 17 |
|
|
2014
Q4 | $2.26M | Sell |
31,324
-1,846
| -6% | -$128K | 1.51% | 16 |
|
|
2014
Q3 | $2.06M | Sell |
33,170
-3,022
| -8% | -$192K | 1.42% | 16 |
|
|
2014
Q2 | $2.31M | Sell |
36,192
-1,275
| -3% | -$77.5K | 1.56% | 16 |
|
|
2014
Q1 | $2.31M | Sell |
37,467
-1,275
| -3% | -$74.3K | 1.59% | 15 |
|
|
2013
Q4 | $2.22M | Sell |
38,742
-1,015
| -3% | -$57.6K | 1.54% | 17 |
|
|
2013
Q3 | $2.12M | Sell |
39,757
-9,908
| -20% | -$533K | 1.56% | 16 |
|
|
2013
Q2 | $2.56M | Buy |
+49,665
| New | +$2.45M | 1.57% | 15 |
|
Other funds holding MDT
VCM
VPM
Roberts, Glore & Co's MDT Position: Q1 2026 in Review
Roberts, Glore & Co increased its Medtronic (MDT) stake by 14% in Q1 2026, buying an estimated $79.9K and bringing the position to 6,997 shares worth $606K. The position accounts for 0.17% of the portfolio, ranked #119.
Roberts, Glore & Co first reported a position in MDT in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.56M in Q2 2013. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Roberts, Glore & Co held 6,997 shares of Medtronic worth $606K as of Q1 2026.
- Roberts, Glore & Co bought 834 Medtronic shares in Q1 2026, an estimated $79.9K.
- Medtronic made up 0.17% of Roberts, Glore & Co's portfolio in Q1 2026, its #119 holding.
- Roberts, Glore & Co first reported a position in Medtronic in Q2 2013 and has held it in 52 quarters since.
- Roberts, Glore & Co's Medtronic position peaked at $2.56M in Q2 2013.
- 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Roberts, Glore & Co's 13F filing for Q1 2026, filed 4 May 2026.